Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan conditioning for allogeneic HSCT
NCT00598624Phase 2Unknown
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2005
- Primary completion
- Dec 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in hematologic malignancy, sponsored by IRCCS Ospedale San Raffaele. Status: unknown.
02
Drugs
treosulfan
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT00598624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598624.